JP2025525308A5 - - Google Patents
Info
- Publication number
- JP2025525308A5 JP2025525308A5 JP2024571035A JP2024571035A JP2025525308A5 JP 2025525308 A5 JP2025525308 A5 JP 2025525308A5 JP 2024571035 A JP2024571035 A JP 2024571035A JP 2024571035 A JP2024571035 A JP 2024571035A JP 2025525308 A5 JP2025525308 A5 JP 2025525308A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- cells
- disease
- ganglioside
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263356557P | 2022-06-29 | 2022-06-29 | |
| US63/356,557 | 2022-06-29 | ||
| PCT/US2023/026541 WO2024006414A1 (en) | 2022-06-29 | 2023-06-29 | Have been novel lipid nanoparticle compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025525308A JP2025525308A (ja) | 2025-08-05 |
| JP2025525308A5 true JP2025525308A5 (OSRAM) | 2026-04-17 |
Family
ID=89381439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024571035A Pending JP2025525308A (ja) | 2022-06-29 | 2023-06-29 | 新規の脂質ナノ粒子組成物およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12303569B2 (OSRAM) |
| EP (1) | EP4547224A1 (OSRAM) |
| JP (1) | JP2025525308A (OSRAM) |
| CN (1) | CN119403544A (OSRAM) |
| AU (1) | AU2023297939A1 (OSRAM) |
| WO (1) | WO2024006414A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120948302A (zh) * | 2024-05-13 | 2025-11-14 | 国立医药品食品卫生研究所 | 使用离心场流分级检测颗粒的方法 |
| WO2025250539A1 (en) * | 2024-05-29 | 2025-12-04 | Cytodigm, Inc. | Pharmaceutical composition comprising sialic acid for treating diseases related to the lung |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150291969A1 (en) * | 2014-01-30 | 2015-10-15 | Chromatin, Inc. | Compositions for reduced lignin content in sorghum and improving cell wall digestibility, and methods of making the same |
| AU2020301161B2 (en) * | 2019-06-25 | 2023-10-26 | Gilead Sciences, Inc. | FLT3L-Fc fusion proteins and methods of use |
| CN116568331A (zh) * | 2020-10-05 | 2023-08-08 | 希托迪格姆公司 | Siglec-结合剂的药物组合物 |
-
2023
- 2023-06-29 JP JP2024571035A patent/JP2025525308A/ja active Pending
- 2023-06-29 AU AU2023297939A patent/AU2023297939A1/en active Pending
- 2023-06-29 CN CN202380047304.0A patent/CN119403544A/zh active Pending
- 2023-06-29 EP EP23832332.3A patent/EP4547224A1/en active Pending
- 2023-06-29 WO PCT/US2023/026541 patent/WO2024006414A1/en not_active Ceased
-
2024
- 2024-09-10 US US18/829,557 patent/US12303569B2/en active Active
- 2024-12-10 US US18/975,168 patent/US20250099394A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lu et al. | Nucleic acid drug vectors for diagnosis and treatment of brain diseases | |
| Tseu et al. | A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast cancer | |
| Zhang et al. | A comprehensive review of small interfering RNAs (siRNAs): mechanism, therapeutic targets, and delivery strategies for cancer therapy | |
| Meng et al. | Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source | |
| Patel et al. | A review: surface engineering of lipid‐based drug delivery systems | |
| Wang et al. | Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy | |
| EP2549986B1 (en) | Multi-compartmental macrophage delivery | |
| Zhou et al. | Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route | |
| Luo et al. | Nanoplatform‐based in vivo gene delivery systems for cancer therapy | |
| Merkel et al. | Nonviral siRNA delivery to the lung: Investigation of PEG− PEI polyplexes and their in vivo performance | |
| Xu et al. | Facile hydrophobization of siRNA with anticancer drug for non-cationic nanocarrier-mediated systemic delivery | |
| Xu et al. | Development of “CLAN” nanomedicine for nucleic acid therapeutics | |
| JP2022542389A5 (OSRAM) | ||
| Afrin et al. | Oral delivery of RNAi for cancer therapy | |
| Guo et al. | Cancer nanomedicines in an evolving oncology landscape | |
| Rahman et al. | Nucleic acid-loaded lipid-polymer nanohybrids as novel nanotherapeutics in anticancer therapy | |
| Khan et al. | Lipid-based colloidal nanoparticles for applications in targeted vaccine delivery | |
| Fang et al. | Roles of exosomes as drug delivery systems in cancer immunotherapy: a mini-review | |
| Parashar et al. | Next-Generation Nucleic Acid Delivery: A Review of Nanobiosystemc Design and Applications | |
| Li et al. | Biomembrane-wrapped gene delivery nanoparticles for cancer therapy | |
| WO2021016106A8 (en) | Multilamellar rna nanoparticles | |
| Puccetti et al. | Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines | |
| CN120676970A (zh) | 用于核酸靶向递送的包含升高的天然脂质和靶向部分的脂质纳米颗粒 | |
| US20220347109A1 (en) | Exosome-Mediated Transfection for Delivery of Nucleic Acids | |
| Almalki et al. | Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics |